CD8A and neoplasm: Conversely, other studies have suggested that IL-10 can enhance the proliferation and activation of CD8+ T cells while suppressing the expression of IFN-g-induced cytokines and specific pro-inflammatory cytokines (IL-12 and IL-6), leading to an anti-tumor effect.